Delivery Order SPE2DB24D2205-SPE2DB25FDSNZ
Award Date
10/10/24
Potential Completion Date
10/11/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $4,647.12 firm-fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $4,647.12 Firm Fixed Price delivery order does not have a set-aside designation and has an ultimate completion date of August 19, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $4,647.12 firm fixed-price delivery order is for 4,564,437,255 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML product, with a completion date of April 30, 2024. The contract has no set-aside designation. Amerisourcebergen, a subsidiary of the larger Cencora, Inc. parent company, holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $8,667.31 firm-fixed-price delivery order is for the supply of 4,565,351,716 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $4,647.12 Firm Fixed Price Delivery Order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The award has an ultimate completion date of September 5, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors....
This federal contract award, valued at $4,906.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of 4,565,477,796 units of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with an ultimate completion date of August 19, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,647.12 firm-fixed-price contract provides for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications, medical supplies, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,338.72 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,647.12 firm fixed price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product. The contract has an ultimate completion date of April 16, 2024. Amerisourcebergen, through its Corporate Office Division, is a well-established supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $4,647.12, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of September 5, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical...